Kimia Biosciences Board Meeting Date
Kimia Biosciences Limited has scheduled a board meeting for November 13, 2026. The board will consider and approve the un-audited standalone financial results for the second quarter.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Kimia Biosciences Limited has scheduled a board meeting for November 13, 2026. The board will consider and approve the un-audited standalone financial results for the second quarter.
Kimia Biosciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Kimia Biosciences Limited announced the re-appointment of Mr. Sameer Goel as Executive Director and changes in designation for three other directors on the board.
Kimia Biosciences Ltd filed the proceedings of its 33rd Annual General Meeting held on September 28, 2026, where shareholders considered various ordinary and special resolutions.
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended March 31, 2026.
Kimia Biosciences Limited has submitted its notice for the 33rd Annual General Meeting scheduled for September 28, 2026, along with the Annual Report for FY 2025-26.
Kimia Biosciences' board meeting outcome includes director appointments, approval of the 33rd AGM notice, and increased borrowing/investment limits. The board also adopted the annual report.